Monographie - Ertapenem

Senaste uppdateringen :
08/05/2024

Ertapenem

Molekylstruktur

Varunamn

Angivna handelsnamn på läkemedel är enbart vägledande då formulering inklusive hjälpämnen kan variera mellan länder och tillverkare

Ertacrit	Indien
Ertagram	Peru
Ertamac	Indien
Invanz	Argentina, Australien, Brasilien, Chile, Colombia, Danmark, Ecuador, Egypten, Finland, Förenade Arabemiraten, Förenta Staterna, Frankrike, Grekland, Irland, Island, Italien, Japan, Kanada, Luxemburg, Malaysia, Marocko, Mexiko, Nederländerna, Norge, Nya Zeeland, Österrike, Peru, Polen, Portugal, Rumänien, Schweiz, Spanien, Storbritannien, Sverige, Turkiet, Tyskland, Ungern, Venezuela
Lyortam	Chile, Peru

Hänvisningar : Ertapenem

	Typ	Publikation
1906	Tidningen	McQuade MS, Van Nostrand V, Shariter J, Kanike JD, Forsyth RJ. Stability and compatibility of reconstituted ertapenem with commonly used iv infusion and coinfusion solutions. Am J Health-Syst Pharm 2004 ; 61: 38-45.
1912	Laboratorium	Ertapenem (Invanz®) - Summary of Product Characteristics Merck Sharp Dohme 2016
1982	Tidningen	Trissel LA, Ogundele AB. Compatibility of anidulafungin with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2005 ; 62: 834-837.
2178	Tidningen	Zajac M, Cielecka-Piontek J, Jelinska A. Stability of ertapenem in aqueous solutions. J Pharm Biomed Anal 2007 ; 43: 445-449.
2247	Tidningen	Chan P, Heatherly K, Kupiec T.C, Trissel L.A. Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2008 ; 12, 3: 276-278.
3208	Tidningen	Phipps Stephen D, Peacock Gina F, Smith Douglas L . Stability of Ertapenem in an Elastomeric Infusion Device. Int J Pharm Compound 2011 ; 15, 3: 252-254.
3254	Tidningen	Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L. Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration Am J Health-Syst Pharm 2011 ; 68: 2265-2270.
3549	Laboratorium	Amikacine B Braun - Résumé des caractéristiques du produit. B Braun 2012
3674	Laboratorium	Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016
3717	Tidningen	Jain J.G, Sutherland C, Nicolau D.P, Kuti J.L. Stability of ertapenem 100 mg/mL in polypropylene syringes stored at 25, 4, and -20 °C. Am J Health-Syst Pharm 2014 ; 71:1480-1484
3824	Tidningen	Boudi S, Roy H, Forest JM, Leclair G. Compatibilité physique de l'association amoxicilline-acide clavulanique en injection avec plusieurs autres médicaments lors d'une administration en Y. Pharmactuel 2023 2023;56,3:91-98
3827	Affisch	Ghazi I.M, Hamada Y, Nicolau D.P. Compatibility of tedizolid phosphate with selected intravenous drugs via simulated Y-site conditions. ASHP Midyear 2015
3828	Affisch	Thabit A.K, Hamada Y, Nicolau D.P. Ceftozolane/tazobactam physical compatibility during simulated Y-site administration. ASHP Midyear 2015
3829	Affisch	So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L. Compatibility of isavunazonium sulfate during simulated Y-site administration. ASHP Midyear 2015
3891	Tidningen	Walker S.E, Law S, Perks W, Iazzetta J. Stability of Ertapenem 100 mg/mL in Manufacturer’s Glass Vials or Syringes at 4°C and 23°C Can J Hosp Pharm 2015 ; 68, 2: 121-126.
3997	Tidningen	Katip W. Visual compatibility of colistin injection with other antibiotics during simulated Y-site administration. Am J Health-Syst Pharm 2017 ; 74:14 : 1099-1102
4055	Tidningen	Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D. Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 , 75, 1:36-44
4145	Tidningen	Asempa T.E, Avery L.M, Kidd J.M, Kuti J.L, Nicolau D.P. Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 ;75,14:1048-1056
4319	Tidningen	Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G. Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs. Hosp Pharm 2020 ; 55, 5: 332-337.
4528	Tidningen	Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N. Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration. Int J Pharm Compound 2021 ;25,1:52-61
4742	Tidningen	Macoviciuc M, Nguyen C, Forest J-M, Leclair G. Compatibilité physique de l’acétaminophène injectable avec 102 autres médicaments lors d’une administration en Y. Pharmactuel 2022 ; 55, 4: 247-255.
4801	Tidningen	Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J. Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration. Am J Health-Syst Pharm 2024 ;51,1:

Mentions Légales